A previous study demonstrated that mutated JAK2 (Janus kinase 2), not dysfunctional RCAN1, may be a common molecular event in leukemia associated with Down syndrome (Bercovich et al. 2008). This evidence concerns the gene JAK2 and Down syndrome.